Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations

Lancet

Volumn 363, Issue 9418, 2004, Pages 1386-1388

  Rosen, Jennifer B ^a,b   Breman, Joel G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHOLERA VACCINE; DIPHTHERIA TOXOID; FANSIDAR; LIVE VACCINE; MALARIA VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE; TETANUS TOXOID;

CHEMOPROPHYLAXIS; CHILD; CHOLERA; CLINICAL TRIAL; DIPHTHERIA; DOSE RESPONSE; HUMAN; HUMORAL IMMUNITY; INFANCY; MALARIA; MEASLES; MENINGITIS; PEDIATRICS; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; SALMONELLOSIS; TETANUS; VACCINATION;

EID: 1942468860     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16052-2     Document Type: Short Survey

References (13)

1. Breman JG. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg. 64:(suppl 1-2):2001;1-11
2. Massaga JJ, Kitua AY, Lemnge MM, et al. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania. Lancet. 361:2003;1853-1860
3. Bradley-Moore AM, Greenwood BM, Bradley AK, et al. Malaria chemoprophylaxis with chloroquine in young Nigerian children. Ann Trop Med Parasitol. 79:1985;563-573
4. Monjour L, Bourdillon F, Froment A, et al. [Measles vaccination in the Sudan-Sahel region of Africa]. Pathol Biol (Paris). 33:1985;232-235
5. Cenac A, Develoux M, Djibo A. Chloroquine treatment of malaria does not increase antibody response to measles vaccination. Trans R Soc Trop Med Hyg. 82:1988;405
6. Greenwood A, Greenwood B, Bradley A. Enhancement of the immune response to meningococcal polysaccharide vaccine in a malaria endemic area by administration of chloroquine. Ann Trop Med Parasitol. 75:1981;261-263
7. Schellenberg D, Menendez C, Kahigwa E, et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants. Lancet. 357:2001;1471-1477
8. Faucher JF, Binder R, Missinou MA, et al. Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis. 35:2002;1147-1154
9. Monjour L, Bourdillon F, Schlumberger M, et al. [Humoral and cellular immunity following antitetanus vaccination in malnourished and malaria-induced African children 1: antitetanus antibody responses]. Bull World Health Organ. 60:1982;589-596
10. McGregor I, Barr M. Antibody response to tetanus toxoid inoculation in malarious and non-malarious Gambian children. Trans R Soc Trop Med Hyg. 56:1962;364-367
11. Greenwood BM, Bradley-Moore AM, Bryceson AD, et al. Immunosuppression in children with malaria. Lancet. 1:1972;169-172
12. Williamson WA, Greenwood BM. Impairment of the immune response to vaccination after acute malaria. Lancet. 1:1978;1328-1329
13. Usen S, Milligan P, Ethevenaux C, et al. Effect of fever on the serum antibody response of Gambian children to Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J. 19:2000;444-449